EPCT-05. A PHASE I TRIAL OF THE CDK 4/6 INHIBITOR PALBOCICLIB IN PEDIATRIC PATIENTS WITH PROGRESSIVE OR REFRACTORY CNS TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

Authors: David Van Mater, Sridharan Gururangan, Sarah Leary, Oren Becher, Joanna Phillips, Jie Huang, Olivia Campagne, Tina Poussaint, Stewart Goldman, Patricia Baxter, Girish Dhall, Giles Robinson, Mariko DeWire-Schottmiller, Eugene Hwang, Clinton Stewart, Arzu Onar-Thomas, Ira Dunkel, Maryam Fouladi

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa222.129

Source: Full article

EPCT-05. A PHASE I TRIAL OF THE CDK 4/6 INHIBITOR PALBOCICLIB IN PEDIATRIC PATIENTS WITH PROGRESSIVE OR REFRACTORY CNS TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

Abstract